All In MedTech

FDA Clearance Tracker · P030039-S026

Coseal Surgical Sealant

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 15, 2021 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jul 15, 2021

Approved

Time to decision

85 days

Received Apr 21, 2021. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P030039-S026
Device name
Coseal Surgical Sealant
Applicant location
Round Lake,, IL
Received
Apr 21, 2021
Decided
Jul 15, 2021
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P030039

Device type

Device class
Class III

Every decision under product code NBE

FDA's approval statement

As written in FDA's record.

Approval for implementation of the BD Sterifill Advanced Syringe as a replacement for the previously used BD Sterifill.

Source documents

Other decisions for Baxter Bio Science

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.